Roundtable Discussion: Tightening Industrial Hygiene, EHS & Process Development Collaborations for an Effective, Safe Scale-up of Novel Potent & Cytotoxic Compound Combining Biologics and Small Molecules

Time: 10:00 am
day: Day Two


• Getting it right first time: internal stakeholders’ involvement during early development for cytotoxic and potent compounds to evaluate process requirement

Selecting right partners and equipment ready for scale-up

• Leverage novel technologies to maximize API yield in contained environments

• Designing Multi-modality suites to enable manufacturing, facility design and equipment procurement strategies to reduce secondary containment requirements